DD283383A5 - Verfahren zur herstellung von neuen 4-chlor-3-sulfamoyl-benzoesaeure-hydraziden - Google Patents

Verfahren zur herstellung von neuen 4-chlor-3-sulfamoyl-benzoesaeure-hydraziden Download PDF

Info

Publication number
DD283383A5
DD283383A5 DD88323775A DD32377588A DD283383A5 DD 283383 A5 DD283383 A5 DD 283383A5 DD 88323775 A DD88323775 A DD 88323775A DD 32377588 A DD32377588 A DD 32377588A DD 283383 A5 DD283383 A5 DD 283383A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
compounds
group
meaning
chloro
Prior art date
Application number
DD88323775A
Other languages
German (de)
English (en)
Inventor
Endre Palosi
Dezsoe Korbonits
Erzsebet Molnar
Ida Szvoboda
Laszlo Harsing
Gyoergy Simon
Sandor Virag
Vera Gergely
Katalin Marmarosi
Original Assignee
�������@���������@��@����������@��������@�����@��Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@���������@��@����������@��������@�����@��Kk�� filed Critical �������@���������@��@����������@��������@�����@��Kk��
Publication of DD283383A5 publication Critical patent/DD283383A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/22—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD88323775A 1987-12-30 1988-12-23 Verfahren zur herstellung von neuen 4-chlor-3-sulfamoyl-benzoesaeure-hydraziden DD283383A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU876131A HU207051B (en) 1987-12-30 1987-12-30 Process for producing 4-chloro-3-sulfamoylbenzoic acid hydrazides and pharmaceutical compositions comprising such compounds

Publications (1)

Publication Number Publication Date
DD283383A5 true DD283383A5 (de) 1990-10-10

Family

ID=10971250

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88323775A DD283383A5 (de) 1987-12-30 1988-12-23 Verfahren zur herstellung von neuen 4-chlor-3-sulfamoyl-benzoesaeure-hydraziden

Country Status (27)

Country Link
US (1) US4916149A (fi)
EP (1) EP0324988B1 (fi)
JP (1) JPH01213269A (fi)
CN (1) CN1037336A (fi)
AT (1) ATE75467T1 (fi)
AU (1) AU609682B2 (fi)
CA (1) CA1332739C (fi)
CS (1) CS277585B6 (fi)
DD (1) DD283383A5 (fi)
DE (1) DE3870601D1 (fi)
DK (1) DK727488A (fi)
ES (1) ES2034149T3 (fi)
FI (1) FI886045A (fi)
GR (1) GR3004471T3 (fi)
HU (1) HU207051B (fi)
IE (1) IE63246B1 (fi)
IL (1) IL88735A (fi)
NO (1) NO172285C (fi)
NZ (1) NZ227481A (fi)
PH (1) PH25739A (fi)
PL (2) PL157971B1 (fi)
PT (1) PT89368B (fi)
RU (2) RU1838303C (fi)
SU (1) SU1736339A3 (fi)
UA (1) UA19123A (fi)
YU (1) YU47125B (fi)
ZA (1) ZA889729B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017065A2 (en) * 1991-04-01 1992-10-15 Duke University Method of inhibiting fibrosis
FR2708608B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
DE10132896A1 (de) * 2001-07-06 2003-01-16 Bayer Cropscience Ag Heterocyclische Amidderivate
DE102005002130A1 (de) * 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1122541B (de) * 1959-12-28 1962-01-25 Hoechst Ag Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren
DE1158927B (de) * 1961-09-15 1963-12-12 Werner Rahms Grubenstempel
DE2144908C2 (de) * 1971-09-08 1982-12-09 Hoechst Ag, 6000 Frankfurt 5-(3- oder 4-Aminobenzolsulfonylamino)-benzimidazolone-(2) und Verfahren zu ihrer Herstellung
BE793718A (fr) * 1972-01-07 1973-07-05 Merck & Co Inc Aminobenzimidazoles
DE2247828A1 (de) * 1972-09-29 1974-04-04 Hoechst Ag Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung
US4420487A (en) * 1978-04-10 1983-12-13 The Purdue Frederick Company Diuretic and antihypertensive benzimidazoles

Also Published As

Publication number Publication date
PT89368B (pt) 1993-08-31
AU2763188A (en) 1989-07-13
YU47125B (sh) 1994-12-28
EP0324988B1 (de) 1992-04-29
DE3870601D1 (de) 1992-06-04
NO172285B (no) 1993-03-22
CA1332739C (en) 1994-10-25
CS910888A3 (en) 1992-09-16
ATE75467T1 (de) 1992-05-15
PH25739A (en) 1991-10-18
AU609682B2 (en) 1991-05-02
HUT56550A (en) 1991-09-30
NO885830L (no) 1989-07-03
IL88735A0 (en) 1989-07-31
NO172285C (no) 1993-06-30
ZA889729B (en) 1989-10-25
RU1838303C (ru) 1993-08-30
HU207051B (en) 1993-03-01
CN1037336A (zh) 1989-11-22
IE883892L (en) 1989-06-30
PT89368A (pt) 1989-12-29
DK727488D0 (da) 1988-12-29
PL157971B1 (pl) 1992-07-31
FI886045A (fi) 1989-07-01
SU1736339A3 (ru) 1992-05-23
NO885830D0 (no) 1988-12-30
ES2034149T3 (es) 1993-04-01
JPH01213269A (ja) 1989-08-28
IL88735A (en) 1992-12-01
EP0324988A1 (de) 1989-07-26
CS277585B6 (en) 1993-03-17
PL158049B1 (pl) 1992-07-31
US4916149A (en) 1990-04-10
YU240188A (en) 1990-10-31
PL276889A1 (en) 1990-04-02
DK727488A (da) 1989-07-01
NZ227481A (en) 1990-11-27
RU1830064C (ru) 1993-07-23
IE63246B1 (en) 1995-04-05
UA19123A (uk) 1997-12-25
GR3004471T3 (fi) 1993-03-31

Similar Documents

Publication Publication Date Title
DE69128236T2 (de) N-Acyl-2,3-benzodiazepin-Derivate, diese enthaltende pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung
DE3143219C2 (fi)
DE1235321B (de) Verfahren zur Herstellung von substituierten Benzimidazolen und ihren Salzen
DE2934747A1 (de) Tetrazolylalkoxycarbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DE2923368C2 (fi)
DE2359536C2 (de) 2,6-Diaminonebularinderivate
DE3521303A1 (de) 4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DE68910211T2 (de) Estramustin-ester.
DE2461802A1 (de) Pyrazinderivate
EP0324988B1 (de) 4-Chlor-3-sulfamoyl-benzoesäure-hydrazide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittelpräparate und Verwendung der neuen Verbindungen zur Herstellung von diuretischen und salzentziehend wirkenden Arzneimittelpräparaten
DE2941592A1 (de) 2,6-diaminonebularine und verfahren zu deren herstellung
DE2619164A1 (de) Indazolyl-(4)-oxy-propanolamine und verfahren zu ihrer herstellung
DE69614553T2 (de) Aromatische carbonsaürediamide mit antigastrin wirkung, ihre herstellung und pharmazeutische verwendung
DE2801478C2 (fi)
DE2329745A1 (de) Therapeutisches mittel und verwendung desselben
DE2261009A1 (de) Neue isochinolinderivate
EP0324184B1 (de) 2-Amino-1,2,3,4-tetrahydroisochinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2035797A1 (de) Neue Nitrofurandenvate , ein Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2043817C3 (de) 1,4-Dihydro-3-carboxy-cyclopentano-(h)-chinolon-(4)-derivate, Verfahren zu deren Herstellung sowie deren Verwendung zur Bekämpfung antibakterieller Erkrankungen
DE2360355C3 (de) l-(Cyanophenoxy)-2-hydroxy-3- [2-(5-1HtetrazolyO-chromonyloxy] - propane
DE2132028A1 (de) Biologisch aktive substituierte Amidine
CH617428A5 (en) Process for the preparation of novel 1-sulphonyl- benzimidazoles
DE1445873A1 (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
DE2360852A1 (de) Neue azabenzo-1,5-diazepine
DE2722399A1 (de) Anti-inflammatorisches mittel, verfahren zu seiner herstellung und daraus hergestellte arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee